Journal Menu

• Home
• Articles
• Special Issues
• Editorial Board
• Aims and Scope
• Author's Instructions
• Editorial Policies
  • 1. Editorial Independence
  • 2. Peer Review Policy
  • 3. AI Policy
  • 4. Open Access Policy
  • 5. Copyright and Licensing
  • 6. Archiving Policy
  • 7. Complaints and Appeals
  • 8. Post-Publication Corrections
  • 9. Citation Policy
  • 10. Author Copies and Reprints
  • 11. Advertising Policy
  • 12. Marketing and Promotion Policy
  • Duties of Editors
  • Duties of Reviewers
• Editorial Process
  • 1. Pre-Check
  • 2. Peer Review
  • 3. Revision
  • 4. Editor Decision
  • 5. Author Appeals
  • 6. Production
  • 7. Editorial Independence
• Peer Review Process
  • 1. Reviewers’ Criteria
  • 2. Diversified Reviewers
  • 3. Peer Review Model
  • 4. Author-Recommended Reviewers
  • 5. Editorial and Peer Review Workflow
  • 6. Transfer of Articles
  • 7. Reviewer's Benefits
  • 8. Conflict of Interest
  • 9. Confidentiality
  • 10. Timelines
  • 11. Peer Review Misconduct
  • 12. Reviewer Citation Manipulation
  • 13. Reviewer's Registration
• Ethical Oversight
  • 1. Authorship
  • 2. AI Use Policy for Authors
  • 3. Plagiarism
  • 4. Redundant Publication
  • 5. Image Manipulation
  • 6. Data Fabrication and Falsification
  • 7. Conflicts of Interest
  • 8. Research Ethics Compliance
  • 9. Consent for Publication
  • 10. Trial Registration
  • 11. Sex and Gender in Research (SAGER)
  • 12. Reporting Guidelines
  • 13. Data Sharing & Reproducibility
  • 14. Publication Ethics Advisors
  • 15. Intellectual Property Policy
• Article Processing Charges and Business Model
  • 1. Article Processing Charges (APCs)
  • 2. Waivers and Discounts
  • 3. Payment Methods
  • 4. Editorial Independence
  • 5. Business Models and Revenue Sources
• Special Issue Guidelines
  • I. Special Issue Policy
  • II. Proposal Making Guidelines
  • III. Submission
  • IV. Ethical Responsibilities of Guest Editors
  • V. Responsibilities of Guest Editors
• Abstracting and Indexing
• Contact Information
• Early Career Researchers
• News
• Insights

Volumes

SCIFINITI ALERT!

Subscribe for research updates and exclusive content straight to your inbox

Choose Journal Computing&AI Connect Communications & Networks Connect GenoMed Connect Molecular Modeling Connect Biomaterials Connect Cancer Research and Therapy Connect Digital Dentistry Connect Sustainable Food Connect Cell Therapy & Engineering Connect Sustainable Processes Connect Clinical Pharmacy Connect Evidence Synthesis in Healthcare Connect Pharmaceuticals and Nanotech Connect Ecological & Sustainable Materials Connect Organic & Medicinal Chemistry Connect Structures and Construction Materials Connect

Subscribe

Welcoming Dr. Eyad Elkord to Cancer Immunology Connect

Published at 2024-08-19

We warmly welcome Dr. Eyad Elkord to the Scifiniti community. We are confident that under his expert leadership, Cancer Immunology Connect will not only thrive but also establish itself as a leading journal in the field. Dr. Elkord’s extensive experience and distinguished reputation will undoubtedly guide this journal toward excellence. We greatly appreciate his commitment to our mission and look forward to his valuable contributions to our team.